 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Passage BIO Inc. (PASG)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-03 Purchase | 2020-03-03 6:35 pm | Passage BIO Inc. | PASG | Cale Edgar B. GC and Corporate Secretary | 2,000 | $18 | $36,000 | 2,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:37 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 8,900 | $18 | $160,200 | 8,900 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:38 pm | Passage BIO Inc. | PASG | Fotopoulos Alexandros CTO | 5,500 | $18 | $99,000 | 5,500 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:40 pm | Passage BIO Inc. | PASG | Goldsmith Bruce A CEO | 1,100 | $18 | $19,800 | 1,100 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:41 pm | Passage BIO Inc. | PASG | Islam Saqib Director | 5,000 | $18 | $90,000 | 5,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:43 pm | Passage BIO Inc. | PASG | Kapadia Sandip Director | 5,000 | $18 | $90,000 | 5,000 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:44 pm | Passage BIO Inc. | PASG | Morris Richard Steven CFO | 400 | $18 | $7,200 | 400 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:46 pm | Passage BIO Inc. | PASG | Quigley Jill M. COO | 2,500 | $18 | $45,000 | 1,000 (Indirect Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:48 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,800 | $18 | $50,400 | 2,800 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:51 pm | Passage BIO Inc. | PASG | Yamada Tadataka Director | 6,500 | $18 | $117,000 | 656,149 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 6:54 pm | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 550,000 | $18 | $9,900,000 | 5,009,219 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 6:57 pm | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 6:59 pm | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 550,000 | $18 | $9,900,000 | 5,009,219 (Direct) | View |
| 2020-03-03 Purchase | 2020-03-03 7:03 pm | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 225,000 | $18 | $4,050,000 | 933,352 (Indirect Direct) | View |
| 2020-02-28 Purchase | 2020-03-03 7:07 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 373,300 | $18 | $6,719,400 | 373,300 (Indirect) | View |
| 2020-03-03 Purchase(A) | 2020-03-13 5:20 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 552,800 | $18 | $9,950,400 | 2,800 (Indirect Direct) | View |
| 2020-03-24 Purchase | 2020-03-25 8:26 pm | Passage BIO Inc. | PASG | Countouriotis Athena Director | 10,000 | $14.98 | $149,750 | 18,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-27 Option Award | 2020-03-02 5:42 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | SQUINTO STEPHEN P Director | 185,776 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:42 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | SQUINTO STEPHEN P Director | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:44 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Quigley Jill M. COO | 211,001 | $18 | 211,001 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:46 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Morris Richard Steven CFO | 74,311 | $18 | 74,311 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:49 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Romano Gary Chief Medical Officer | 74,311 | $18 | 74,311 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:50 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Fotopoulos Alexandros CTO | 74,311 | $18 | 74,311 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:52 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Cale Edgar B. GC and Corporate Secretary | 99,731 | $18 | 99,731 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:54 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:55 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Islam Saqib Director | 16,918 | $18 | 16,918 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:56 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Kapadia Sandip Director | 16,918 | $18 | 16,918 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:58 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:01 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:03 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Yamada Tadataka Director | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:05 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Countouriotis Athena Director | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 2,977,242 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 1,049,175 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 432,802 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 2,977,242 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 1,049,175 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:54 pm | N/A N/A | Passage BIO Inc. | PASG | Heron Patrick J Director 10% Owner | 432,802 | $0 | 5,009,219 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 2,977,242 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 1,049,175 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:57 pm | N/A N/A | Passage BIO Inc. | PASG | Woiwode Thomas Director 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 2,977,242 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 1,049,175 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 432,802 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 2,977,242 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 1,049,175 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 6:59 pm | N/A N/A | Passage BIO Inc. | PASG | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner | 432,802 | $0 | 5,009,219 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 2,977,242 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 1,049,175 | $0 | 933,352 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-03 7:03 pm | N/A N/A | Passage BIO Inc. | PASG | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner | 708,352 | $0 | 933,352 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 3,721,552 | $0 | 373,300 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 1,311,469 | $0 | 373,300 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 541,002 | $0 | 373,300 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 3,721,552 | $0 | 373,300 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 1,311,469 | $0 | 373,300 (Indirect) | View |
| 2020-02-28 Conversion | 2020-03-03 7:07 pm | N/A N/A | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 541,002 | $0 | 373,300 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,800 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,800 (Indirect) | View |